Aktiesnakken — November 2010
-
masha det må du gerne uddybe. Hvorfor skulle Merck vente med at file for et stof
-
som HAR opnået signifikans i de primære endpoints
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
og Bager henviser hele tiden til Merck - som om han end ikke er informeret?